The US Food and Drug Administration has targeted Akorn Inc. with faulty root cause investigations into problems with impurities and bottle defects, poor aseptic practices and inadequate control over computer equipment in a 13 June warning letter. The agency also blasted the firm for not fixing past good manufacturing practice problems.
The main GMP deficiency seen in the warning letter, poor root cause investigations, seems to be part of growing trend...